Testosterone Prior Authorization: Why It Gets Denied and How to Get It Approved

Testosterone prior authorization is your insurance plan's sign-off before it will pay for testosterone. Your prescriber sends records. The plan checks them against its own checklist. Missing labs, product rules, or renewal limits can lead to denial. The written reason and your plan type decide whether to correct the request, seek an exception, or appeal.

Here's the part most people never hear about. A rejection can have nothing to do with how low your testosterone is. It's the time printed on your lab report. We'll show you the window shared by four documents with explicit clock rules.

By TRT Provider Guide · Last verified: October 21, 2026 Editorial research from 15 insurer, pharmacy-benefit, Medicare, Medicaid, and TRICARE documents, plus federal appeal rules. Not clinically reviewed.

Last updated: October 21, 2026.

---

Who this guide is for: Adults sorting out insurance coverage for testosterone. The lab rules below come from policies for adult men with hypogonadism — a condition where the body doesn't make enough testosterone. Testosterone for gender-affirming care, women, or teens follows different coverage rules. Ask your plan for the policy that matches your diagnosis.

Start with what you were told

Jump to the free worksheet to log your status, reason, and deadline →

What changes the answer for you:

• Your plan type. Employer plans, Marketplace plans, Medicare Part D, Medicare Advantage, Medicaid, and TRICARE all use different rules and different clocks.
• The exact product. Some plans prefer generic injections; others prefer generic gels. Pills, nasal gel, Xyosted, Aveed, and pellets can need extra steps.
• Whether you're new to treatment or already on it. Several documents accept fewer historical diagnostic results for men already taking testosterone; current monitoring requirements still vary.
• Your lab timing and numbers. Some plans use a hard 300 ng/dL cutoff. Others use the lab's own normal range.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

This page is educational information, not medical advice. Your clinician decides on testing and treatment. If you have chest pain, trouble breathing, sudden weakness on one side, or another emergency, call 911.

What we actually verified — October 21, 2026

Sources checked: 15 testosterone coverage documents (Cigna, UnitedHealthcare, Aetna, CVS Caremark, FEP Blue, Blue Cross NC, Kaiser Permanente, Health Net, Indiana Medicaid, West Virginia Medicaid, TRICARE, Highmark); federal appeal rules from HealthCare.gov, the Department of Labor, CMS, and the Code of Federal Regulations; FDA and HHS testosterone labeling announcements; a GoodRx price-table snapshot; and the public insurance, pricing, pharmacy, state, and terms pages of Hone Health, Male Excel, and Taurus Meds.

Verified: What each document says, on the date we read it. The federal deadlines in our timing table. Provider policies as published on October 21, 2026.

Provider-stated (not tested by us): Hone's, Male Excel's, and Taurus Meds' prices and published services or terms; Hone's and Male Excel's pharmacy and state information. We did not verify an assigned clinician's or dispensing pharmacy's license for an individual patient.

What we could not confirm: Whether your plan uses any of these documents. How fast plans actually decide in practice. Approval or appeal success rates for testosterone specifically.

What we did not do: Submit a prior authorization, file an appeal, call an insurer, or buy treatment.

---

What is testosterone prior authorization, and who has to file it?

Testosterone prior authorization is a review your health plan does before it agrees to cover a testosterone product. Your prescriber's office usually submits it, with your diagnosis, lab reports, and treatment history. An approval means the plan agreed to cover the drug under its rules; it does not guarantee what you'll pay.

Plans have different names for it. Aetna calls it precertification. FEP Blue calls it prior approval. Medicare drug plans decide whether prior-authorization requirements are met through a coverage determination. That term also covers other drug-benefit decisions, including exceptions and payment disputes. CMS explains the process.

Testosterone is a Schedule III controlled substance — a federal category for drugs with legitimate medical use and some potential for misuse. It always needs a valid prescription, and many plans review it before the first fill and again at renewal. DEA scheduling reference.

Keep three decisions separate

People get stuck because three different decisions feel like one:

1. The medical decision. Your clinician decides whether treatment makes sense for you.
2. The coverage decision. Your plan decides whether your records meet its checklist.
3. The payment decision. Your claim decides what the plan pays and what you owe. HealthCare.gov is clear that preauthorization is not a promise the plan will pay.

A denial is about #2. It is not a ruling that you don't have low testosterone.

Pharmacy benefit or medical benefit?

Ask your prescriber's office which one your request went through. It changes which rules apply.

---

Why was my testosterone prior authorization denied?

The documents we checked describe several reasons a request can fail: no request on file, missing or badly timed lab results, symptoms not documented, a non-preferred product, a safety lab outside the plan's limit, or a renewal that didn't meet continuing rules. The written reason tells you whether to resubmit, ask for an exception, or file an appeal.

We built this decoder from the 15 plan documents we read. Find the line that matches your letter.

The denial decoder

Log your denial reason in the worksheet so your prescriber sees exactly what to fix →

Resubmit, exception, or appeal — which one are you in?

These are three different tools. Check which process the plan will accept and keep any appeal deadline in view.

• Resubmit (or correct) when something was missing or wrong — one lab instead of two, no draw time, a typo. Ask whether the plan accepts a corrected request, and protect any existing appeal deadline.
• Exception request when the plan prefers a different product, has a quantity limit, or the drug isn't on the formulary. Your prescriber explains why the alternative won't work for you.
• Appeal when you want formal review of a denial. A denial for missing records can also be appealed. Follow the appeal instructions and deadline while gathering the evidence the plan needs.

One warning. Don't assume a resubmission, a peer-to-peer call, or a phone complaint stops your appeal clock. Ask the plan to confirm in writing, and keep the denial notice's deadline on your calendar either way.

---

What does insurance require for testosterone? We compared 15 plan documents

Most plan documents we read want two low testosterone results, drawn in the early morning on different days, plus documented symptoms. But the details change outcomes: some plans use a fixed 300 ng/dL cutoff while others use the lab's own range, several accept one result for men already on treatment, and some add safety limits for hematocrit and PSA.

Here's the side-by-side. Every row comes from the plan's own document. These are coverage rules, not medical diagnoses — and your plan may use a different document, so treat this as a map of what to ask for.

Testosterone prior authorization criteria — 15 documents, verified October 21, 2026

Sources are linked in each row and at the end of this page. These are selected adult-hypogonadism criteria, not each document's full checklist. “Checked” gives our reading date when no reliable version date was shown. A policy listing does not prove current product availability: Cigna marks Androderm obsolete.

What the 15 documents tell us

Two morning results is the norm in this sample — not a universal coverage rule. Most documents want two. The cited Blue Cross NC sections and Indiana form request a qualifying level without expressly specifying two separate draws in those fields. That does not replace the clinician's diagnostic workup.

"Low" means different numbers at different plans. Cigna, Aetna, and CVS Caremark's commercial program lean on the lab's own range. FEP Blue uses under 300 ng/dL; UnitedHealthcare also accepts the lab's range, and the cited Johns Hopkins form has a specialist alternative. The Indiana form's cypionate section uses 350 or less. The same result of 310 ng/dL can satisfy one lab criterion and miss another—not establish approval on its own.

Already on testosterone? Your old labs still matter. Cigna, Aetna, and CVS Caremark's continuation rules look back at one low result from before you started. Cigna dropped its "lost records" pathway in a 2026 revision, so men switching plans need those original reports.

"Age-related" exclusions are still live. Aetna's July 2026 policy review and CVS Caremark's 2026 program both still exclude age-related low testosterone. That's notable, because in June 2026 HHS announced that FDA was asking makers to remove the old label line saying testosterone's safety and effectiveness weren't established for age-related low testosterone. A requested label change doesn't rewrite plan policies on its own. Your prescriber can explain whether the requested change or the product's current label supports your appeal. Read the June 2026 HHS announcement.

Brands can sit behind other products. The documents show injection or topical steps for Xyosted, Azmiro, some testosterone pills, and Natesto. Some Cigna drug lists require Jatenzo before Kyzatrex or Tlando.

Safety labs can block approval. FEP Blue requires hematocrit — the share of your blood made of red blood cells — under 54%, and PSA (prostate-specific antigen, a prostate blood test) under 4 ng/mL for men over 40, with a prostatectomy exception. The Medicare Part B criteria we read exclude hematocrit over 48%. These are coverage rules, not personal treatment targets or proof that treatment is safe.

A coverage cutoff is not a diagnosis

The Endocrine Society says hypogonadism should be diagnosed only when a man has symptoms or signs of testosterone deficiency and consistently low, accurately measured testosterone, confirmed with a repeat morning fasting test. Endocrine Society guidance. The American Urological Association uses under 300 ng/dL as a reasonable cutoff to support a diagnosis, alongside symptoms and two early-morning total-testosterone tests on separate occasions. AUA guideline. No single number diagnoses you — and no plan's cutoff does either. See our TRT eligibility requirements and low-testosterone testing guide for the clinical side.

How to find your plan's actual policy

1. Log in to your member portal and search the drug list (formulary) for the exact product.
2. Look for "PA," "ST" (step therapy), or "QL" (quantity limit) next to it.
3. Click through to the criteria, or call the number on your card and ask: "Which testosterone prior authorization policy applies to my plan, and can you send it to me?"
4. Check the back of your card for a PBM name (CVS Caremark, Express Scripts, Optum Rx). That's often who reviews pharmacy requests.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to explore online TRT programs and the questions to ask before you pay.

A quick heads-up so you know what you're getting: the tool is built for men weighing online TRT programs. It won't file or fix a prior authorization. The worksheet on this page helps you organize the records and next steps.

Answer 5 quick questions in Find My TRT Path → (Free, no email, educational only — it doesn't diagnose low testosterone or guarantee a prescription.) Privacy policy.

---

Do you really need two testosterone tests — and what time should you get them?

For a new start, usually yes: most plans we checked want two low results on different days, drawn in the morning. Several also set a clock window. A fasting draw from 8:00 a.m. to before 10:00 a.m. on separate days falls within the four explicit clock windows below; that shared window does not satisfy every other plan or clinical requirement.

Here's the open loop from the top of the page, closed.

Testosterone runs highest in the morning, which is why plans care. A 2 p.m. draw can come back lower and still get rejected because of when it was drawn. Your clinician decides what to test and when. This helps you ask about the applicable clock rule; it does not guarantee approval.

What to bring back from each draw

• Collection date and time printed on the report
• Fasting status, if the plan asks
• The lab's reference range (the "normal" range printed next to your number)
• Lab name — and the same lab both times if your plan requires it
• Total testosterone, plus free testosterone if your clinician ordered it

Total testosterone is all the testosterone in your blood. Free testosterone is the small part not attached to proteins. Most is attached to proteins, including SHBG (sex hormone-binding globulin) and albumin. Some conditions push SHBG up or down—that's why a few plans accept a free-testosterone result instead. How total and free testosterone differ.

If you were sick, short on sleep, or drew in the afternoon, ask your clinician whether a repeat makes sense before resubmitting.

---

How long does testosterone prior authorization take?

It depends on your plan and the kind of request. Medicare Part D initial drug-benefit requests generally use 72-hour standard and 24-hour expedited clocks, with a special start rule for exceptions. The essential health benefits (EHB) nonformulary exception process also uses 72 and 24 hours; appeals have different deadlines.

Track two clocks: your deadline to file, and the plan's deadline to decide.

Days below are calendar days unless stated otherwise. Decision clocks generally start when the right decision-maker receives the request; exceptions are noted. These are federal rules for the named processes. Check your notice for the applicable process and any stronger state or plan protections.

Decision and appeal clocks, checked October 21, 2026

A few rules can change those clocks:

• Missing records: an allowed ERISA extension to obtain information can pause the decision clock; the plan generally must allow at least 45 days to supply it. Incomplete urgent claims have separate prompt-response rules. This does not automatically extend your appeal-filing deadline.
• More than one appeal level: some group plans split the standard review period between two required levels. Do not assume a fresh 180-day filing window for the second level; special rules also apply to some collectively bargained plans. ACA appeal protections generally apply to non-grandfathered coverage.
• External review: the issue and process must qualify. In some urgent cases, you can seek outside review without finishing the usual internal appeal.
• Medicaid: extensions require an enrollee request or a permitted reason involving needed information and the enrollee's interests. Certain expedited hearings use a three-working-day deadline after the state gets the managed-care file. Fee-for-service Medicaid and some integrated Medicare-Medicaid plans follow different routes.

ERISA rules. ACA review rules. Medicaid appeal rules. Hearing deadlines.

Where the time really goes

A delay can occur before submission, during review, or while additional records are being gathered. Ask your prescriber's office three things:

1. "What date did you send it?"
2. "Did you send it electronically or by fax?"
3. "What's the reference number?"

Urgent review generally depends on the risk of serious harm from waiting under that process's rules. You can request it; your prescriber's explanation can be important. For an EHB nonformulary exception, an ongoing course using the nonformulary drug is also an expressly qualifying circumstance. Ask which rule applies. Don't call something urgent to cut the line. EHB exception rule.

The CMS rule with 2026 deadlines excludes drug prior authorization

CMS finalized a rule in 2024 whose prior-authorization process requirements generally began in 2026. Its seven-day standard decision limit applies to specified Medicare Advantage, Medicaid, and CHIP payers; that turnaround provision excludes Marketplace plans on the federal exchange. The rule's prior-authorization requirements cover medical items and services, not drugs. CMS proposed additional drug requirements in April 2026. As of this update, that's still a proposal. Final-rule fact sheet. Current proposed-rule page.

---

How to appeal a testosterone insurance denial, step by step

Read the written reason, get the exact policy the plan used, gather the relevant evidence with your prescriber, and submit the appropriate request before its deadline. You can file a member appeal, or work with an authorized representative or prescriber as the process permits. If the internal appeal fails, your next review route depends on the benefit and the issue.

KFF found that consumers appealed fewer than 1% of denied in-network post-service claims from reporting HealthCare.gov insurers in 2023; insurers upheld 56% of those denials on appeal. These data exclude prior-authorization requests and do not measure testosterone appeal success. Whether to appeal depends on the denial reason, available evidence, and your review rights. Read the original analysis.

Step 1: Get the complete decision in writing

Keep the notice. Note the date on it and the date you got it. Find the denied product, the reason, the policy name, the appeal address or portal, the deadline, and the instructions for standard or urgent review.

Step 2: Ask for the policy the plan used

Ask for the clinical criteria and records used in the decision, by name. ERISA and ACA appeal rules provide rights to relevant records and criteria without charge; other benefits have their own rules. Now you can see the exact line the plan says you didn't meet. Your appeal and records rights.

Step 3: Match the reason in the decoder

Use the decoder above. It helps you identify whether to correct a request, seek an exception, or appeal a denial; confirm the process in your notice.

Step 4: Gather the evidence that answers the reason

• Both lab reports, with collection times and reference ranges
• A visit note listing your symptoms and how long you've had them
• Products you've actually tried, with dates and what happened
• Safety labs (hematocrit, PSA) if the plan requires them
• Earlier approvals, if this is a renewal or a new plan

Step 5: Confirm who will submit it

Coordinate with your prescriber's office about who will file. You can file a member appeal, while your prescriber supplies the medical explanation. Check whether anyone filing for you needs a representative form or your written consent. Many plans also allow a peer-to-peer review — a phone call between your prescriber and the plan's reviewing doctor. Ask your prescriber to request one if the plan offers it.

What a strong letter of medical necessity covers (share this list with your prescriber — the medical content must come from them):

• The diagnosis, and whether a cause was looked for
• Both lab results with dates, times, values, and ranges
• Symptoms and how long they've lasted
• Products tried, with dates and outcomes
• Safety labs and the monitoring plan
• The guidelines that support the request (Endocrine Society 2018; American Urological Association 2018, reaffirmed 2024)

Step 6: Put the deadline on your calendar

For a first internal appeal, ERISA employer plans and plans subject to ACA appeal rules generally allow at least 180 days after you receive the denial. First Part D and Medicare Advantage appeals generally use 65 days from the notice date; Medicaid managed-care appeals use 60 days from the notice date. Original Medicare uses a different claims-appeal process. Check the instructions and the correct starting date for your case.

Step 7: If it's upheld, go outside the plan

Commercial external review uses an independent reviewer when the issue and process qualify. After a Part D denial on appeal, you generally must request the next review by an Independent Review Entity; do not assume it happens automatically. Medicare Advantage generally forwards an upheld denial for independent review. Medicaid managed care leads to a state fair hearing after the plan appeal. Not every issue qualifies for commercial external review—a benefit-contract exclusion alone may fall outside it. Follow the next-step instructions in the decision. Part D. Medicare Advantage. External review.

Step 8: Keep a call log

Date, name, department, reference number, what they said. You'll be glad you did.

Use the appeal cover-letter organizer — fill in the blanks, attach your records, send →

---

"They want me to try a different testosterone first" — step therapy

Many plans cover generic testosterone injections or generic gels first and approve brands like Xyosted, Jatenzo, Kyzatrex, Tlando, Natesto, or Azmiro only after the preferred options fail or can't be used. An exception request needs real dates, what was tried, and why it didn't work — or a medical reason it isn't safe for you.

What counts as a real reason? Documented side effects. A product that didn't raise your levels after a fair trial. Or a safety reason — for example, testosterone gel can rub off on children and partners through skin contact, which some plans recognize. FDA AndroGel labeling.

What doesn't count: Preference alone, usually. And never report a trial that didn't happen.

FDA-approved vs. compounded — plans treat them very differently

FDA-approved means the FDA reviewed that exact finished product for safety, effectiveness, and quality. FDA-approved commercial testosterone products include generic testosterone cypionate injections, Depo-Testosterone, AndroGel, Testim, Vogelxo, Xyosted, Jatenzo, Kyzatrex, Tlando, Natesto, Aveed, and Testopel. FDA product review. Kyzatrex label.

Compounded testosterone is prepared by a compounder rather than approved as that finished drug by FDA. FDA says compounded drugs are not FDA-approved and aren't reviewed for safety, effectiveness, or quality before they're sold. They are not generic versions of approved drugs. UnitedHealthcare's cited policy calls compounded hormone products, including pellets, unproven and not medically necessary. Ask your plan about the exact preparation; neither a prescription nor an approved ingredient establishes coverage or approval of the compounded product. FDA on compounded drugs.

---

Why was my testosterone renewal denied?

A renewal can be denied for missing recent labs, an on-treatment result outside the plan's range, or a safety requirement that is not met. Some documents set continuing-treatment limits—FEP Blue uses 800 ng/dL or less, while West Virginia prints a 400–600 range without units. Others also look back at your labs from before you started.

Renewal rules, side by side

You may have heard that "insurance stops covering you once your levels are normal." That's not what most documents we checked say. Some continuation rules look back at your pre-treatment labs. A few cap your on-treatment level. Know which kind your plan uses.

One firm line: if an on-treatment level is outside your plan's range, that's for your prescriber to interpret. Don't change your dose to fit a policy.

Set a reminder 30–45 days before your approval ends. Renewal paperwork takes time, and a lapse can leave you between refills.

---

Already on testosterone, switched plans, or started at a cash clinic?

Moving to insurance depends on your new plan's rules and your records from before treatment. The cited Cigna, Aetna, and CVS Caremark policies accept one low pre-treatment result for men already on therapy, along with their other criteria. If those original lab reports are gone, these paths get much harder.

Find your baseline labs

• Your old clinic's patient portal or records department
• The lab's patient portal (Quest and Labcorp both have one)
• A written records request—HIPAA generally gives you access to records held by covered providers and labs, with limited exceptions and possible copying or mailing charges. HHS explains access rights.

Label them clearly in your packet: "Before treatment" and "During treatment."

What cash clinics will and won't do for insurance

Many online TRT programs are cash-only and won't help with insurance paperwork. As of October 21, 2026:

• Hone Health says it doesn't accept insurance and doesn't complete prior authorizations. If you use insurance at a local pharmacy, Hone says you'll coordinate the prior authorization with your insurer yourself. That does not remove the plan's need for prescriber evidence. Hone's policy.
• Male Excel says it doesn't accept insurance and doesn't provide letters of medical necessity. Its terms also require agreement that reimbursement claims will not be submitted to commercial insurance or government health programs for its services or products. FAQ. Terms.

So if insurance is the goal, you'll usually need an in-network clinician who can order the right labs, file the request, and send the prescription to a pharmacy your plan covers. Our guide to TRT providers that take insurance covers which care routes actually bill plans.

If you have no pre-treatment labs at all, your clinician decides whether a supervised re-evaluation is appropriate. Never stop or change testosterone on your own to "get new numbers." Stopping can cause real symptoms, and it's a medical decision. Our guide on how to switch TRT providers walks through the transfer.

---

Does Medicare, Medicaid, or an employer plan change the next step?

Yes — the appeal path follows the benefit that made the decision. Medicare can cover different products through Part D or Part B, but Original Medicare and Medicare Advantage use different appeal paths. Medicaid rules follow federal requirements plus state and plan rules; employer-plan routes also depend on whether coverage is insured or self-funded.

Medicare

The Part B criteria we read in The Health Plan's 2026 documents (CVS Caremark 5777-A P2025, jurisdictions J and M) are strict: two fasting tests before 10 a.m. from the same lab, an LH or FSH test, PSA and a prostate exam within 12 months, hematocrit no higher than 48%, and no coverage for aging-related low testosterone. LH (luteinizing hormone) and FSH (follicle-stimulating hormone) are hormones from the pituitary gland that signal the testicles. They help show why testosterone is low.

Online prescribers and 2027 renewals: federal telemedicine rules that let qualifying clinicians prescribe controlled substances like testosterone without an in-person visit run through December 31, 2026. The extension allows qualifying audio-video prescribing by DEA-registered clinicians, subject to federal and state law; it does not remove state practice rules or guarantee remote access. If your prescriber is online-only, ask how care and any required in-person visit will be handled after that date. DEA's current extension.

Medicaid

Medicaid is state-run under federal rules, often through a managed-care plan. First approvals can be short (3 months in West Virginia), and some states won't cover testosterone requested only for ED or infertility. After a managed-care plan appeal, you can request a state fair hearing. Fee-for-service Medicaid follows the state agency's notice and hearing process; the managed-care filing windows above do not apply to it. If an existing benefit is being cut, ask right away about keeping it during the appeal — that deadline is usually much shorter.

Employer plans: insured or self-funded?

Ask your benefits office whether your plan is fully insured or self-funded. A big insurer's name can be on the card of a self-funded plan, so you can't tell by looking. It changes who regulates the plan and which outside review applies. For employer plans under ERISA (the federal law covering most private-sector employer plans), the Department of Labor's Employee Benefits Security Administration answers questions about claims and appeals.

---

Is fighting the prior authorization worth it?

For generic testosterone cypionate, GoodRx's public table listed $48.79 for one 10 mL vial at 200 mg/mL on October 21, 2026—a drug-only snapshot, not a local quote or a month's treatment. For brands like Xyosted, testosterone pills, Natesto, or Aveed, compare the exact cash quote with your covered cost before deciding. Count visits, labs, and supplies too, not just the drug.

The hybrid route most people miss

You can keep your in-network doctor for visits and labs — often covered — and simply pay cash for a generic at the pharmacy when that's cheaper than your copay. Agree on the monitoring plan with your clinician, and check what your plan covers for visits and labs.

Ask your pharmacist two prices: your plan price and the cash or coupon price. Compare both prices and the effect on your deductible. GoodRx purchases do not automatically count toward it; ask whether your insurer accepts receipts for possible credit or reimbursement. GoodRx explains this limit.

While you wait

Tell your prescriber and pharmacist right away if the coverage fight might leave you without medication. Ask who to call if no decision arrives by your next refill date. Your clinician — not an appeal letter — decides whether any treatment change is needed.

See what testosterone cypionate really costs, with and without insurance →

---

Done fighting insurance? Your cash options, honestly compared

If your plan excludes testosterone, or the math favors cash, you have three main routes: your own clinician plus a cash pharmacy price, an online program with published membership pricing, or a fully managed online program. Each trades price, convenience, product type, and paperwork differently. Hone says it does not complete prior authorizations; Male Excel says it does not accept insurance or provide letters of medical necessity; Taurus's prior-authorization help was not verified.

Find your route

Hone Health

Best for: A man who wants online care with follow-up labs and physician consults bundled into one monthly fee, and who may want the option to fill at a local pharmacy.

Not for you if: you need someone to file a prior authorization, or you live where the Plus plan priced below is unavailable: Alabama, Alaska, Arkansas, Connecticut, Delaware, Washington D.C., Kansas, Louisiana, Minnesota, New Hampshire, New Jersey, New York, North Dakota, Pennsylvania, Rhode Island, or South Carolina. Hone lists New York under its separate Premium plan. Hone's state table was checked October 21, 2026.

Hone does not file prior authorizations or bill insurance. If getting this PA approved is your priority, your in-network doctor is the better route — full stop. Hone publishes a membership fee with scheduled follow-up labs and physician consults built in, and it says it can send an eligible prescription to the pharmacy you choose—where a coupon cash price may beat your copay. The membership fee continues, and the pharmacy charges separately for medication. Outside-pharmacy terms.

What Hone publishes (provider-stated, checked October 21, 2026):

Startup testing plus 12 months of membership comes to $1,710 with lab confirmation ($45 + $45 + $1,620), before medication. With home confirmation, that subtotal is $1,745 ($45 + $80 + $1,620). Both assume 12 monthly Plus charges at the published rate. Published Plus pricing. Hone's prices are estimates and vary by prescription. Its cream and troche are compounded, and its testosterone cypionate product page carries a compounded disclosure — ask which exact product and pharmacy you'll get. More in our Hone TRT cost guide.

Membership can bill in months without a medication shipment. Hone's Plus page lists included shipping for its own fulfillment; a local pharmacy sets its own charges. Get the exact product, supply quantity, refill dates, and total pharmacy charges before comparing annual costs.

Before you cancel: Hone's billing page says cancellation is immediate, while its membership FAQ says it takes effect at the end of the billing period. Confirm the applicable cancellation date, any remaining charges, and refund terms in writing before paying.

Does that fit your situation? Review Hone's published Plus pricing → (Treatment depends on a clinician's evaluation.)

Male Excel

Best for: A man who is finished with insurance and wants a managed program — a dedicated provider, unlimited e-visits, and a check-in every 60 days — with daily small-needle injections.

Not for you if: you want insurance to pay, need a letter of medical necessity, want an FDA-approved finished product, want to use your own pharmacy, or live in Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire, or Rhode Island.

What Male Excel publishes (provider-stated, checked October 21, 2026):

A 12-month subtotal at those unchanged starting rates is $2,727 before shipping ($99 + $1,188 membership + $1,440 medication). Prices change with your prescribed dose. This is not an individual first-year quote: confirm actual refill and billing dates, shipping, any taxes, and fees for extra tests or required outside care. A 60-day supply and “every other month” billing do not by themselves establish every charge within 365 days. Published pricing. Terms.

Know these before you pay:

• Male Excel describes the testosterone treatment discussed here as compounded and not FDA-approved.
• The package bundles thyroid medication with testosterone. Ask why it's being prescribed for you and what the plan costs without it.
• Its FAQ names Anazao Health Corp. and WellDyneRx-Fl. Its terms, checked October 21, 2026, describe contracted third-party pharmacies and say prescriptions won't be sent elsewhere. Pharmacy and service FAQ.
• Prescription sales are generally final, and the refill notice gives you 48 hours to act before billing and shipment. A separate conditional guarantee covers the initial three months of membership fees, not medication costs: a refund can be requested if symptoms do not improve after 90 days of participation and adherence, with the request made within 30 days after that period.
• It says an in-person exam may be required under DEA and state rules. The price of any outside exam and whether a repeat early-morning diagnostic test costs extra were not established by the quoted package; ask before paying.

Full details are in our Male Excel cost guide.

Its pricing page says there is no contract and you can cancel at any time. The terms say the effective cancellation date follows its cancellation policy; confirm that date and any pending refill charge. Ask how to obtain your original lab reports and visit notes for a future transfer.

If that's the trade you want, review Male Excel's published pricing → (A licensed provider decides whether treatment is appropriate.)

---

When a denial is really telling you something medical

Some denials flag a real health issue — a high hematocrit, an abnormal PSA, untreated severe sleep apnea, near-term fertility plans, or signs of a pituitary or testicular problem. Those need a clinician's evaluation before treatment, not a better appeal letter.

The Endocrine Society guideline supports clinical review of these risks. See primary care, urology, endocrinology, or reproductive urology first if:

• Your hematocrit is high. Testosterone can raise red blood cell levels. Plans cap it for a reason.
• Your PSA is high, or you have a prostate nodule or a history of prostate or breast cancer.
• You want children soon. Testosterone from outside the body can suppress spermatogenesis — sperm production. The Endocrine Society advises against starting testosterone in men planning fertility in the near term. Medicines like clomiphene, enclomiphene, or hCG are not testosterone replacement, aren't interchangeable with it, and can't promise to protect fertility. Their approval status also differs: clomiphene use in men is off-label; enclomiphene is not FDA-approved; hCG products such as Pregnyl have an approved indication for selected cases of male hypogonadotropic hypogonadism, where pituitary signals are too low. Clomiphene label. Enclomiphene status. Pregnyl label. See our TRT and fertility guide.
• You had a heart attack or stroke recently, or you have untreated severe sleep apnea or uncontrolled heart failure.
• Your testosterone is very low with low LH and FSH, or you have headaches with vision changes. A pituitary workup may be needed. Guideline evaluation pathway.
• Your symptoms could have another cause — poor sleep, thyroid problems, depression, medication effects, diabetes, or weight change.

Chest pain, trouble breathing, sudden severe headache, fainting, or weakness on one side? Call 911.

---

Your prior authorization and appeal worksheet

Write down the medicine, benefit type, status, exact reason, missing evidence, who's responsible, and your deadline. Bring this to every call and every office visit. It turns "insurance won't cover it" into a short list of specific tasks with names and dates.

Keep this for yourself. Don't post completed health or insurance details in public comments.

A. The request

B. Match the reason to the evidence

C. Track the process

D. Questions to ask your plan

1. Is this a pharmacy rejection, an incomplete request, or a formal denial?
2. Which exact policy and benefit are you using?
3. Which requirement is missing or not met?
4. Do you need lab results from before treatment, recent results, or both?
5. Is there a required morning time window or fasting rule for the labs?
6. If you prefer another product, what exception process and evidence do you accept?
7. Which form and submission method do we need?
8. What's my filing deadline, and when does your decision clock start?
9. Does a peer-to-peer call or resubmission affect my appeal deadline? Please confirm in writing.
10. If you uphold the denial, what's my next review option and deadline?

E. Appeal cover-letter organizer

Use this to appeal a written denial, along with any form your plan requires. The medical explanation must come from your clinician.

To: [Plan appeals department and address or portal]
From: [Your name and contact details]
Member ID: [ID]
Case or denial reference: [Reference number]
Decision date: [Date on the notice]
Subject: Request for review of denial for [exact medicine]

I am requesting review of the decision above. The notice gives this reason: "[Copy the reason exactly.]"

I am asking the plan to [approve coverage of / grant an exception for] [exact medicine]. The attached records address the reason as follows:

• [Requirement the plan says wasn't met] — [document, date, page]
• [Requirement the plan says wasn't met] — [document, date, page]
• Letter from my prescriber, dated [date]

Please confirm you received this request, tell me if anything is still missing, and tell me the date your decision is due. Please send the written decision and any further appeal rights to [address or email].

Attachments: [List only what you actually included.]
Signature and date: [Sign as your plan requires.]

Don't add a diagnosis, a failed treatment, a side effect, or an urgent situation that isn't true. If someone is filing for you, check whether your plan needs a signed representative form.

---

How we built this page

We read 15 testosterone coverage documents from commercial insurers, pharmacy benefit managers, Medicare plans, Medicaid programs, and TRICARE, including documents dated 2023–2026 and undated forms checked October 21, 2026, and compared them on the same points. We checked appeal deadlines against federal rules and separated what each document says from our own conclusions.

We picked documents that show meaningful differences — commercial pharmacy and medical policies, Medicare Part B and Part D, Medicaid, and TRICARE. This is a sample, not every plan in the country. We didn't average thresholds, score insurers, or predict approval odds.

The provider section uses each company's own published pages, checked on the dates shown. Our editorial method is How We Review TRT Providers: we separate verified facts, provider-stated facts, customer-experience signals, and our own conclusions, and we show known costs, calculation assumptions, and unresolved fees instead of treating teaser prices as complete bills.

This page has not been clinically reviewed. Our editorial standards explain how we handle evidence and conflicts. If a policy changes or you spot an error, please send documentation through our corrections process.

---

Testosterone prior authorization FAQ

Your plan's exact policy and the written reason for its decision determine the next step. These answers separate coverage rules from clinical diagnosis and point back to the relevant records and deadlines.

Why does testosterone need prior authorization?

Plans use it to check that testosterone is being prescribed for a covered condition with the right documentation. Testosterone is a Schedule III controlled substance, and many plans also screen out uses they exclude, such as performance enhancement. Many review it again at renewal.

Who submits the prior authorization — me or my doctor?

Your prescriber's office usually submits it, because it needs clinical records and the prescriber's signature. You can push it along: get the denial, ask for the policy, gather your lab reports, and check the deadline. You can also file an appeal yourself as the member.

What testosterone level does insurance require?

There's no single number. FEP Blue uses under 300 ng/dL; UnitedHealthcare also accepts the lab's range. Cigna, Aetna, and CVS Caremark's cited programs use lab ranges or guideline-based results. The cited Johns Hopkins USFHP form also has a specialist pathway, and the Indiana form's cypionate section uses 350 or less. Some plans accept a low free testosterone result instead. A coverage cutoff is not a diagnosis.

How many testosterone tests does insurance need?

Most plans we checked want two low results on different days for a new start. The cited Blue Cross NC sections and Indiana form request a qualifying level without expressly specifying two separate draws in those fields. That does not replace a clinician's diagnostic workup. Several continuation policies accept one low result from before treatment, plus their other criteria.

What time should testosterone blood work be drawn for insurance?

In the morning. Aetna's form sets 7:00–10:00 a.m., FEP Blue 8:00–10:00 a.m., a Medicare Part B criteria set before 10 a.m., and Highmark before 11 a.m. A fasting draw from 8:00 a.m. to before 10:00 a.m. falls within those four clock windows. Your clinician decides the appropriate tests and timing; other plan requirements still apply.

How long does testosterone prior authorization take?

Part D initial drug-benefit requests generally use 72 hours standard or 24 hours expedited, with a special start rule for exception statements. EHB nonformulary exceptions also use 72/24 hours. ERISA requests before care generally start with a 15-day limit, subject to permitted extensions and missing-information rules. See the timing table for appeal deadlines.

It's on the formulary — so why won't they authorize it?

Being on the formulary means the drug can be covered. A "PA" or "ST" flag next to it means you still have to meet the plan's criteria or try a preferred product first. Approval also doesn't guarantee what you'll pay.

Why was my renewal denied when I've been on testosterone for a year?

Possible reasons include missing recent labs, an on-treatment level outside the plan's renewal range, or an unmet safety requirement. FEP Blue uses a total-testosterone limit of 800 ng/dL or less. Health Net's adult continuation criteria include prior/current qualifying therapy or an applicable continuity-of-care route, positive response, and dose limits; its no-reauthorization clause is for delayed puberty.

Can I switch from a cash TRT clinic to insurance?

It depends on the new plan, the prescribed product, and your records from before treatment. The cited Cigna, Aetna, and CVS Caremark policies accept one low pre-treatment result for men already on therapy, along with their other criteria. You'll usually need an in-network clinician, because many cash clinics don't file prior authorizations.

Do online TRT clinics do prior authorization?

Many don't. As of October 21, 2026, Hone Health says it doesn't complete prior authorizations, and Male Excel says it doesn't accept insurance or provide letters of medical necessity. If insurance is your goal, an in-network clinician is usually the better route.

Will insurance cover compounded testosterone?

Check the exact preparation and benefit. Compounded drugs are not FDA-approved; an approved ingredient does not make a compounded finished product approved. The cited UnitedHealthcare policy calls compounded hormone products, including pellets, unproven and not medically necessary. Neither a prescription nor FDA approval by itself guarantees coverage.

Does Medicare cover testosterone?

It can. Home-use testosterone runs through Part D or a Medicare Advantage drug plan. Office-given shots and pellets can fall under Part B, where regional rules apply. The Part B criteria we read exclude aging-related low testosterone and require PSA, a prostate exam, and hematocrit checks.

Did the 2026 FDA announcement make insurers cover testosterone for "age-related" low T?

No. In June 2026, HHS announced that FDA asked manufacturers to remove the old label limitation about age-related low testosterone. That doesn't automatically change plan policies — Aetna's July 2026 review still lists age-related hypogonadism as unproven. Your prescriber can explain whether the requested change or the product's current label is relevant to your appeal.

Is an appeal worth it?

It can be worth pursuing when the denial reason can be answered with relevant evidence or the policy was applied incorrectly. The KFF data above exclude prior-authorization requests, so they do not give your testosterone appeal odds. Compare the covered cost, cash cost, review deadline, and any ongoing-treatment need with your prescriber.

Does an approval mean I've been diagnosed with low testosterone?

No. An approval means your records met a coverage checklist. Diagnosis comes from your clinician, based on symptoms, repeat morning testing, and a look for the cause.

---

Still weighing online TRT programs? Use our free Find My TRT Path tool. It's educational and doesn't diagnose low testosterone, decide eligibility, or guarantee a prescription.

Educational information, not medical advice. TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, drug manufacturer, insurer, or medical practice. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Plan rules, prices, and federal rules change; your plan's coverage documents and applicable law govern your rights. Last verified October 21, 2026.

---

Sources

Plan and coverage documents

• Cigna IP0350 — Testosterone (Oral, Topical, and Nasal) Products, effective June 15, 2026
• Cigna IP0351 — Testosterone (Injectable) Products, effective October 15, 2026
• UnitedHealthcare — Testosterone Replacement or Supplementation Therapy, effective January 1, 2026
• Aetna CPB 1014 — Testosterone Cypionate Injections, reviewed July 13, 2026
• Aetna — Prescription Medication Precertification Request, GR-68988
• CVS Caremark — Testosterone Products 1210-A, P03-2026
• FEP Blue — 5.30.031 Testosterone Topical, effective July 1, 2026
• CVS Caremark — Medicare Part B Testosterone Supplementation, Jurisdictions J and M, plan year 2026
• Blue Cross NC — 2026 Basic NCSC Medicare Part D criteria, updated September 2026
• Kaiser Northwest / MedImpact — All PA Guidelines, testosterone chapters effective February and July 2026
• Health Net — Clinical Policy CP.CPA.291 Testosterone
• Indiana Medicaid — Testosterone PA Request Form (UnitedHealthcare Community Plan)
• West Virginia Medicaid — Testosterone Agents PA Criteria
• Johns Hopkins USFHP — TRICARE Testosterone Cypionate, Enanthate, and Xyosted PA Form
• Highmark — Testosterone Prior Authorization Form

Appeal rules and timelines

• HealthCare.gov — Preauthorization definition
• HealthCare.gov — Internal appeals
• HealthCare.gov — External review
• HHS — Internal Appeals and External Review overview
• 45 CFR 156.122 — Prescription drug benefits (exception requests)
• U.S. Department of Labor — Filing a Claim for Health Benefits
• 42 CFR 423.568 — Medicare Part D standard coverage determinations
• CMS — Redetermination by the Part D Plan Sponsor
• CMS — Reconsideration by the Medicare Advantage Plan
• 42 CFR 438.402 — Medicaid managed care appeals
• 42 CFR 438.408 — Medicaid appeal resolution and state fair hearings
• CMS — 2026 Interoperability Standards and Prior Authorization for Drugs Proposed Rule fact sheet
• KFF — Claims Denials and Appeals in ACA Marketplace Plans in 2023

Medical and regulatory

• Endocrine Society — Testosterone Therapy for Hypogonadism guideline
• American Urological Association — Testosterone Deficiency Guideline
• HHS — FDA requests updates to testosterone therapy labeling, June 18, 2026
• FDA — Compounding and the FDA: Questions and Answers
• DEA — Drug Scheduling
• Federal Register — Fourth Temporary Extension of Telemedicine Flexibilities

Prices and providers

• GoodRx — Testosterone cypionate prices
• Hone Health — Do You Accept Insurance?
• Hone Health — Plus Membership
• Hone Health — Service Availability by State
• Male Excel — Hormone Treatment Costs
• Male Excel — TRT FAQs
• Male Excel — Terms and Conditions

Additional sources for the distinctions above

• Johns Hopkins USFHP — Oral testosterone undecanoate prior-authorization form
• 29 CFR 2560.503-1 — ERISA claims and appeals procedures
• 45 CFR 147.136 — Internal appeals and external review
• CMS — Part D coverage determinations
• 42 CFR 423.572 — Expedited Part D determinations and exception timing
• Medicare.gov — Appeals in Original Medicare
• CMS — First-level Original Medicare redetermination and 120-day filing period
• 42 CFR 431.244 — Medicaid hearing decisions
• HHS — Your medical records and access rights
• CMS — Interoperability and Prior Authorization Final Rule, CMS-0057-F
• CMS — Current proposed drug prior-authorization rule, CMS-0062-P
• Endocrine Society — Full 2018 testosterone clinical practice guideline
• AUA — Original 2018 guideline article, readable copy
• FDA — Review identifying approved testosterone products
• FDA — Kyzatrex prescribing information
• FDA — AndroGel prescribing information and secondary-exposure warning
• FDA — Compounded-drug risks and approval status
• FDA — Clomiphene prescribing information
• FDA — Enclomiphene regulatory-status presentation in the June 8, 2022 advisory-committee transcript
• Operation Supplement Safety — Clomiphene and enclomiphene status, January 2026
• FDA — Pregnyl prescribing information
• DEA — Fourth telemedicine extension through December 31, 2026
• GoodRx — Purchases and deductible credit
• Hone — Outside-pharmacy prescriptions
• Hone — Testosterone cypionate product and compounded disclosure
• Hone — Membership and medication billing
• Hone — Membership frequently asked questions
• Male Excel — Terms and conditions
• Male Excel — Excel Advantage membership-refund terms
• Male Excel — Published membership and six-month testing services
• Taurus Meds — $49/$149 offer
• Taurus Meds — General terms and healthcare member fees